13C-urea breath test to validate eradication of Helicobacter pylori in an Israeli population

Israel Medical Association Journal

Volumn 5, Issue 2, 2003, Pages 98-100

  Gal, Eyal ^a,b   Abuksis, Galia ^a,b   Fraser, Gerald ^a,b   Koren, Rivka ^a,b   Shmueli, Chaim ^a,b   Yahav, Yaakov ^a,b   Niv, Yaron ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

13C urea breath test; Eradication therapy; Helicobacter pylori

Indexed keywords

ANTIBIOTICS; ANTIBODIES; LABORATORIES; PATIENT MONITORING;

SEROLOGY;

BACTERIA;

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; UREA; ANTIINFECTIVE AGENT; DIAGNOSTIC AGENT;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DYSPEPSIA; FEMALE; GENDER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISRAEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; NONHUMAN; NURSE; OUTCOMES RESEARCH; PHYSICIAN; PREDICTION; PRIMARY HEALTH CARE; QUESTIONNAIRE; RACE DIFFERENCE; TREATMENT FAILURE; UREA BREATH TEST; VALIDATION PROCESS; ADOLESCENT; BREATH ANALYSIS; DRUG COMBINATION; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BREATH TESTS; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ISRAEL; MALE; MIDDLE AGED; TREATMENT OUTCOME; UREA;

EID: 0037289691     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Everhart JE. Recent development in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 2000;29:559-78.
2. Williams MP, Pounder RE. Helicobacter pylori: From the benign to the malignant. Am J Gastroenterol 1999;94: (Suppl):s11-6.
3. Logan RP. Urea breath tests in the management of Helicobacter pylori infection. Gut 1998;43 (Suppl 1):s47-50.
4. Sheu BS, Lee SC, Yang HB, Lin XZ. Quantitative results of 13C urea breath test at 15 minutes may correlate with the bacterial density of H. pylori in the stomach. Hepatogastroenterology 1999;46:2057-62.
5. Hawtin P.R. Serology and urea breath test in the diagnosis of H. pylori infection. Mol Biotechnol 1999;11:85-92.
6. Perri F, Clemente R, Pastore M, et al. The 13C urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest 1998;58:19-27.
7. Savarino V, Vigneri S, Celle G. The 13C urea breath test in the diagnosis of Helicobacter pylori infection. Gut 1999;45(Suppl 1):18-22.
8. Cutler AF, Prasad VM. Long term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 1996;91:85-8.
9. Perez-Perez GI, Culter AF, Blaser MJ. Value of serology as a noninvasive method for evaluation the efficacy of treatment of Helicobacter pylori infection. Clin Infect Dis 1997;25:1038-43.
10. Lind T,Veldhuyzen Van Zanten SJO, Unge P. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials - The MACH 1 study. Helicobacter 1996;1:138-44.
11. Malfertheiner P, Megraud F, O'Morain C, et al. Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997;9:1-2.
12. Moayyedi P, Chalmers DM, Axon AT. Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 1997;32:24-7.
13. Avidan B, Weiss B, Chowers Y, Younash A, Bar-Meir S, Keler N. Sensitivity and resistance of Helicobacter pylori to antibiotic treatment. Harefuah 1999;137:272-4 (Hebrew).
14. Weisfeld AS, Simmons DE, Vance PH. In vitro susceptibility of pretreatment isolates of Helicobacter pylori from the multicenter United States clinical trials Gastroenterology 1996;110:A295.
15. McColl K, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1869-74.
16. Annibale B, D'Ambra G, Luzzi I, et al. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients? Am J Gastroenterol 1997;92:790-4.
17. Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A. Prediction of failure of helicobacter pylori eradication with the standard "Maastricht triple therapy". Aliment Pharmacol Ther 2001;15:1023-9.
18. Georgopoulos SD, Ladas SD, Karatapanis S, et al. Factors that may affect treatment outcome of triple helicobacter pylori eradication therapy with omeprazole, amoxicillin and clarithromycin. Dig Dis Sci 2000;45:63-7.
19. Spiller RC. Is there any difference in helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? Eur J Gastroenterol Hepatol 1999;11(Suppl 2):S25-8, S43-5.